Symptomatic Venous Thromboembolism Vte clinical trials

Explore recruiting symptomatic venous thromboembolism vte clinical trials.

Recruiting symptomatic venous thromboembolism vte studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Symptomatic Venous Thromboembolism Vte trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Multicenter, Randomized, Open-Label, Study to Evaluate REGN7508, A Factor XI Monoclonal Antibody, Versus Apixaban and Enoxaparin for Prophylaxis of Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-APEX).

Bulgaria, Lithuania, Poland, Hungary, Latvia, Romania

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Multicenter, Double-Blinded, Randomized Study to Evaluate REGN7508, a Factor XI Monoclonal Antibody, Versus Acetylsalicylic Acid for Prophylaxis of Symptomatic Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-ASPEN)

Greece, Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Enhanced recovery and Abbreviated Length of Anticoagulation for Thromboprophylaxis after primary Hip Arthroplasty – the ENABLE-Hip Trial

Germany, Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

Symptomatic Venous Thromboembolism Vte trials by city

Symptomatic Venous Thromboembolism Vte in Toronto Symptomatic Venous Thromboembolism Vte in Vancouver Symptomatic Venous Thromboembolism Vte in Montreal Symptomatic Venous Thromboembolism Vte in Calgary Symptomatic Venous Thromboembolism Vte in Edmonton Symptomatic Venous Thromboembolism Vte in Ottawa Symptomatic Venous Thromboembolism Vte in Winnipeg Symptomatic Venous Thromboembolism Vte in Quebec City Symptomatic Venous Thromboembolism Vte in Hamilton Symptomatic Venous Thromboembolism Vte in Kitchener Symptomatic Venous Thromboembolism Vte in London Symptomatic Venous Thromboembolism Vte in Halifax Symptomatic Venous Thromboembolism Vte in New York Symptomatic Venous Thromboembolism Vte in Los Angeles Symptomatic Venous Thromboembolism Vte in Chicago Symptomatic Venous Thromboembolism Vte in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease